Roiver Score™ for
FBIOFortress Biotech, Inc.
Based on fundamentals through 12/31/2025.
As of December 31, 2025, Fortress Biotech, Inc. (FBIO) scores 17/100 (Weak) on the Roiver Score — a transparent quality composite. Its strongest area is capital structure; its weakest is stability. The score measures business quality, not timing — it's a signal, not a recommendation.
No black box
Roiver Score is a transparent 0–100 quality composite. Five components, each 0–20: profitability, capital structure, cash quality, valuation, and stability. Inspired by Piotroski's F-Score, Altman's Z-Score, and the Buffett/Munger framework on quality compounders at fair prices. Read the full methodology →
Frequently asked about FBIO
What is FBIO's Roiver Score?
Fortress Biotech, Inc. scores 17 out of 100 (Weak) as of December 31, 2025, based on fundamentals.
How is the Roiver Score for FBIO calculated?
It sums five 0–20 components — profitability, capital structure, cash quality, valuation, and stability — into a transparent 0–100 composite. The full methodology is published.
Is FBIO a good quality stock?
On quality, FBIO rates "Weak" (17/100). Its strongest driver is capital structure and its weakest is stability. Quality is one input to a decision, not a buy/sell call.
Embed on your site
Drop this iframe into a Substack, blog post, or notion page. Updates automatically as fundamentals change.
<iframe src="https://roiver.com/embed/score/FBIO" width="640" height="280" frameborder="0" style="border:0;border-radius:16px;overflow:hidden" loading="lazy"></iframe>
Get FBIO's Score in your inbox
A free weekly digest of quality scores and what changed. No account needed.
Educational use only. Roiver Score is a quality signal, not a recommendation.